Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 384,670 | 364,507 | 331,551 | 291,793 | 366,999 |
| Marketable Securities | 262,908 | 276,826 | 277,369 | 270,027 | 467,433 |
| Receivables | 378,891 | 383,928 | 422,660 | 383,471 | 395,974 |
| Inventories | 520,642 | 513,852 | 516,245 | 523,503 | 484,667 |
| Other current assets | 0 | 0 | 79,017 | 74,392 | 0 |
| TOTAL | $1,767,494 | $1,766,810 | $1,757,479 | $1,674,543 | $1,903,036 |
| Non-Current Assets | |||||
| PPE Net | 440,326 | 430,876 | 414,401 | 425,076 | 418,530 |
| Investments And Advances | 382,913 | 420,241 | 377,870 | 354,733 | 0 |
| Intangibles | 827,770 | 776,969 | 783,958 | 789,759 | 778,801 |
| Other Non-Current Assets | 49,248 | 46,482 | 55,082 | 36,297 | 382,454 |
| TOTAL | $1,700,257 | $1,674,568 | $1,631,311 | $1,605,865 | $1,579,785 |
| Total Assets | $3,467,751 | $3,441,378 | $3,388,790 | $3,280,408 | $3,482,821 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 125,461 | 130,864 | 148,510 | 131,899 | 129,119 |
| Accrued Expenses | 134,905 | 133,048 | 130,658 | 133,218 | 118,782 |
| Other current liabilities | 189,893 | 183,011 | 116,573 | 143,779 | 135,753 |
| TOTAL | $480,248 | $481,251 | $487,472 | $462,885 | $431,244 |
| Non-Current Liabilities | |||||
| Long Term Debt | 435,607 | 435,611 | 435,615 | 435,541 | 732,800 |
| Deferred Revenues | N/A | N/A | 26,390 | N/A | N/A |
| Other Non-Current Liabilities | 301,952 | 291,913 | 116,871 | 257,742 | 247,835 |
| TOTAL | $737,559 | $727,524 | $714,596 | $693,283 | $980,635 |
| Total Liabilities | $1,217,807 | $1,208,775 | $1,202,068 | $1,156,168 | $1,411,879 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,869 | 28,819 | 28,794 | 28,695 | 28,591 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 1,644,416 | 1,612,785 | 1,606,117 | 1,575,981 | 1,577,861 |
| Other shareholders' equity | 351,184 | 372,497 | 340,616 | 316,225 | 267,293 |
| TOTAL | $2,249,944 | $2,232,603 | $2,186,722 | $2,124,240 | $2,070,942 |
| Total Liabilities And Equity | $3,467,751 | $3,441,378 | $3,388,790 | $3,280,408 | $3,482,821 |